Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients

During the past few years, new immunosuppressants, such as tacrolimus, mycophenolate mofetil (MMF) and basiliximab, have been shown to successfully decrease the incidence of acute rejection, possibly acting as potent substrates for safe steroid withdrawal. Therefore, clinical outcome of 3 months ste...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Chang-Kwon, Kim, Su Jin, Kim, Ji Hye, Lee, Jong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314843/
https://www.ncbi.nlm.nih.gov/pubmed/22468094
http://dx.doi.org/10.3346/jkms.2012.27.4.337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314843/
https://www.ncbi.nlm.nih.gov/pubmed/22468094
http://dx.doi.org/10.3346/jkms.2012.27.4.337

Ejemplares similares